• Profile
Close

Use of cardiac resynchronization therapy defibrillator in US hospitals

JAMA Jun 25, 2019

Sandhu A, et al. – Researchers determined whether the use of cardiac resynchronization therapy defibrillator (CRT-D) changed with the American College of Cardiology/American Heart Association/Heart Rhythm Society guideline update in 2012. The study sample consisted of 88,923 patients undergoing initial CRT-D implantation, of which 83.1% were guideline concordant. Overall, they noted an increased rate of guideline-concordant CRT-D implantation during the study, and the major fraction of guideline-discordant implants were clustered at a minority of hospitals. Conduction abnormalities correlated with guideline-discordant implants, which suggested further opportunity for dissemination and understanding of guideline updates.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay